AdpA, a Pleiotropic Transcriptional Regulator, Is Involved in the Cascade Regulation of Lincomycin Biosynthesis in .

Lincomycin is one of the most important antibiotics in clinical practice. To further understand the regulatory mechanism on lincomycin biosynthesis, we investigated a pleiotropic transcriptional regulator AdpA in the lincomycin producer NRRL 2936. Deletion of (which generated Δ ) interrupted lincomycin biosynthesis and impaired the morphological differentiation. We also found that putative AdpA binding sites were unusually scattered in the promoters of all the 8 putative operons in the lincomycin biosynthetic gene cluster (BGC). In Δ , transcript levels of structural genes in 8 putative operons were decreased with varying degrees, and electrophoretic mobility shift assays (EMSAs) confirmed that AdpA activated the overall putative operons via directly binding to their promoter regions. Thus, we speculated that the entire lincomycin biosynthesis is under the control of AdpA. Besides, AdpA participated in lincomycin biosynthesis by binding to the promoter of which encoded a cluster sited regulator (CSR) LmbU of lincomycin biosynthesis. Results of qRT-PCR and catechol dioxygenase activity assay showed that AdpA activated the transcription of . In addition, AdpA activated the transcription of the by binding to its promoter, suggesting that AdpA indirectly participated in lincomycin biosynthesis and morphological differentiation. Uncommon but understandable, AdpA auto-activated its own transcription via binding to its own promoter region. In conclusion, we provided a molecular mechanism around the effect of AdpA on lincomycin biosynthesis in , and revealed a cascade regulation of lincomycin biosynthesis by AdpA, LmbU, and BldA.